Free Trial

GoodRx (GDRX) Earnings Date, Estimates & Call Transcripts

GoodRx logo
$4.52 +0.03 (+0.67%)
(As of 05:36 PM ET)
Get GoodRx Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GoodRx and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

GDRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GDRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

GoodRx Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.04$0.04$0.04 
Q2 20241$0.03$0.03$0.03 
Q3 20241$0.03$0.03$0.03 
Q4 20241$0.02$0.02$0.02 
FY 20244$0.12$0.12$0.12 
Q1 20251$0.05$0.05$0.05 
Q2 20251$0.06$0.06$0.06 
Q3 20251$0.06$0.06$0.06 
Q4 20251$0.06$0.06$0.06 
FY 20254$0.23$0.23 $0.23

GoodRx Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/8/2024Q2 2024$0.09$0.08 -$0.01$0.02$200.47M$200.60M
5/9/2024Q1 2024$0.04$0.03 -$0.01$0.06$196.20M$197.88M
2/29/2024Q4 2023$0.02$0.02-$0.10$195.59M$196.64M
11/9/2023Q3 2023$0.06$0.06-$0.09$188.52M$180.00M
8/9/2023Q2 2023$0.01$0.02+$0.01-$0.10$186.90M$189.68M
5/10/2023Q1 2023$0.01$0.01-$0.03$181.87M$183.99M
2/28/2023Q4 2022-$0.01$0.01+$0.02$0.02$178.17M$184.11M

GoodRx Earnings - Frequently Asked Questions

GoodRx issued an update on its fourth quarter 2024 earnings guidance on Thursday, November, 7th. The company issued revenue guidance of $200.0 million-$200.0 million, compared to the consensus revenue estimate of $206.3 million.

GoodRx (NASDAQ:GDRX) has a recorded annual revenue of $790.39 million.

GoodRx (NASDAQ:GDRX) has a recorded net income of -$8.87 million. GDRX has generated -$0.03 earnings per share over the last four quarters.

GoodRx (NASDAQ:GDRX) has a forward price-to-earnings ratio of 34.77. The price/earnings-to-growth ratio is 3.54.

GoodRx's earnings are expected to grow from $0.13 per share to $0.18 per share in the next year, which is a 38.46% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:GDRX) was last updated on 12/26/2024 by MarketBeat.com Staff
From Our Partners